|
C8ORF83 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.10919999996018E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.352710E-04 |
| Normal-vs-Stage2 |
1.88050000005102E-06 |
| Normal-vs-Stage3 |
4.14010000004961E-06 |
| Normal-vs-Stage4 |
1.614010E-04 |
| Stage1-vs-Stage2 |
1.928290E-02 |
| Stage1-vs-Stage3 |
1.709400E-01 |
| Stage1-vs-Stage4 |
2.919600E-01 |
| Stage2-vs-Stage3 |
3.346200E-01 |
| Stage2-vs-Stage4 |
3.954600E-01 |
| Stage3-vs-Stage4 |
9.800800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.03599999982052E-07 |
| Normal-vs-AfricanAmerican |
1.344050E-02 |
| Normal-vs-Asian |
2.127900E-02 |
| Caucasian-vs-AfricanAmerican |
7.268800E-01 |
| Caucasian-vs-Asian |
1.275820E-01 |
| AfricanAmerican-vs-Asian |
5.101000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.04729999999853E-05 |
| Normal-vs-Female |
2.29760000003409E-06 |
| Male-vs-Female |
9.178400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.343600E-03 |
| Normal-vs-Age(41-60Yrs) |
9.32249999974211E-07 |
| Normal-vs-Age(61-80Yrs) |
1.44660000001018E-06 |
| Normal-vs-Age(81-100Yrs) |
2.282200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.651700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.494300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.309200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.721200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.113200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.702200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.282600E-01 |
| Classical-VS-Follicular |
4.550500E-02 |
| Classical-VS-Other |
4.376800E-01 |
| Classical-VS-Normal |
8.22610000000834E-05 |
| Tall-VS-Follicular |
5.349400E-01 |
| Tall-VS-Other |
4.654200E-01 |
| Tall-VS-Normal |
3.143100E-03 |
| Follicular-VS-Other |
1.721030E-01 |
| Follicular-VS-Normal |
4.11779999998085E-06 |
| Other-VS-Normal |
4.768200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.81200000004544E-07 |
| Normal-vs-N1 |
2.083400E-03 |
| N0-vs-N1 |
3.186400E-01 |
|
|
